Stock BIOVIT BIO VITOS PHARMA AB
Add to a list
To use this feature you must be a member
Log inSign up

News Bio Vitos Pharma AB

Equities

BIOVIT

SE0009320278

Market Closed - Nasdaq Stockholm
Other stock markets
 17:00:00 20/06/2024 BST 		5-day change 1st Jan Change
0.125 SEK +1.63% Intraday chart for Bio Vitos Pharma AB -3.85% -47.48%
05-13 Bio Vitos Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02-14 Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Bio Vitos Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Bio Vitos Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Bio Vitos Pharma Teams Up with KFUM Kalmar to Explore Benefits of Iron Succinate for Female Athletes
MT
KFUM Kalmar and Bio Vitos Pharma enter into an agreement regarding a research study on Succifer
AQ
KFUM Kalmar and Bio Vitos Pharma Sign Collaboration Agreement to Conduct Research Study on Succifer
CI
The European Patent Office EPO grants patent that is important to Bio Vitos Pharma
AQ
The European Patent Office EPO Grants Patent to Bio Vitos Pharma AB
CI
Hemcheck Sweden AB will Change its Ticker to BIOVIT from HEMC
CI
Hemcheck Sweden AB will Change its Name to Bio Vitos Pharma AB
CI
Hemcheck Sweden AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Hemcheck completes the transaction with Bio Vitos
AQ
Hemcheck Sweden AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Hemcheck has received a first order from its distributor Astemed
AQ
Hemcheck Sweden AB Receives A First Order from Its Distributor Astemed
CI
Hemcheck Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Hemcheck submits a formal application to Nasdaq for a decision on continued listing before the implementation of the Bio Vitos agreement
AQ
Additional follow up order from the Foundation for Innovative New Diagnostics (FIND)
AQ
Hemcheck Sweden Receives New Follow Up Order from the Foundation for Innovative New Diagnostics
CI
Hemcheck has received a first order from the university hospital Charité in Berlin
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIOVIT Stock
  4. News Bio Vitos Pharma AB